Director/PDMR Shareholding
Novacyt S.A. announced that its CEO, Lyn Rees, purchased 73,379 ordinary shares at an average price of €0.3899, Chairman John Brown acquired 73,762 ordinary shares at an average price of €0.3899, and Non-Executive Director Ian Gilham bought 28,750 ordinary shares at £0.34415. These transactions occurred on March 26 and 27, 2026, on Euronext and AIM markets respectively, indicating director confidence in the company.
Select text to share a quote on X · sign in to keep highlights & notes in your NCYT notes
Paris, France, and Manchester, UK - 30 March 2026 - Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), the international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces that it has been notified that, on 26 and 27 March 2026, the following Directors purchased ordinary shares of €1/15 each in the Company (the "Ordinary Shares"):
| Director | Title | Number of Ordinary Shares purchased | Average price paid per Ordinary Share | Resultant beneficial holding | % of issued share capital | ||||||||
| Lyn Rees | CEO | 73,379 | €0.3899 | 73,379 | 0.00% | ||||||||
| John Brown | Chairman | 73,762 | €0.3899 | 73,762 | 0.00% | ||||||||
| Ian Gilham | NED | 28,750 | £0.34415 | 28,750 | 0.00% | ||||||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | ||||||||||||
| a) | Name 1) Lyn Rees 2) John Brown 3) Ian Gilham | 1) CEO 2) Chairman 3) NED | |||||||||||
| 2. | Reason for the Notification | ||||||||||||
| a) | Position/status | See 1(a) - classified as a PDMR of the Company | |||||||||||
| b) | Initial notification/ Amendment | Initial Notification | |||||||||||
| a) | Name | Novacyt S.A. | |||||||||||
| b) | LEI | 213800BWAC2BF295EG28 | |||||||||||
| a) | Description of the Financial instrument, type of instrument | ordinary shares of €1/15 each | |||||||||||
| Identification code | FR0010397232 | ||||||||||||
| b) | Nature of the transaction | Acquisition of Ordinary Shares | |||||||||||
| c) | Price(s) and volume(s) 1) Lyn Rees 2) John Brown 3) Ian Gilham |
Price Volume €0.3817 15,228 €0.3919 56,732 €0.3950 1,802 Price Volume £0.34415 28,750 | |||||||||||
| d) | Aggregated information: · Aggregated volume · Price 1) Lyn Rees 2) John Brown 3) Ian Gilham |
Price Volume €0.3899 73,762 Price Volume £0.34415 28,750 | |||||||||||
| e) | Date of the transaction | 1 & 2) 26 and 27 March 2026 3) 27 March 2026 | |||||||||||
| f) | Place of the transaction | 1 & 2) Euronext and 3) AIM |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.